| Literature DB >> 36153410 |
Qiangqiang Li1,2,3, Rongliang Wang1,3,4, Zhe Zhang1,3,4, Haixing Wang1, Xiaomin Lu1,3,5, Jiajun Zhang1,4, Alice Pik-Shan Kong6, Xiao Yu Tian7, Hon-Fai Chan8, Arthur Chi-Kong Chung6, Jack Chun-Yiu Cheng1,4, Qing Jiang9, Wayne Yuk-Wai Lee10,11,12.
Abstract
Exercise in later life is important for bone health and delays the progression of osteoporotic bone loss. Osteocytes are the major bone cells responsible for transforming mechanical stimuli into cellular signals through their highly specialized lacunocanalicular networks (LCN). Osteocyte activity and LCN degenerate with aging, thus might impair the effectiveness of exercise on bone health; however, the underlying mechanism and clinical implications remain elusive. Herein, we showed that deletion of Sirt3 in osteocytes could impair the formation of osteocyte dendritic processes and inhibit bone gain in response to exercise in vivo. Mechanistic studies revealed that Sirt3 regulates E11/gp38 through the protein kinase A (PKA)/cAMP response element-binding protein (CREB) signaling pathway. Additionally, the Sirt3 activator honokiol enhanced the sensitivity of osteocytes to fluid shear stress in vitro, and intraperitoneal injection of honokiol reduced bone loss in aged mice in a dose-dependent manner. Collectively, Sirt3 in osteocytes regulates bone mass and mechanical responses through the regulation of E11/gp38. Therefore, targeting Sirt3 could be a novel therapeutic strategy to prevent age-related bone loss and augment the benefits of exercise on the senescent skeleton.Entities:
Year: 2022 PMID: 36153410 DOI: 10.1038/s41418-022-01053-5
Source DB: PubMed Journal: Cell Death Differ ISSN: 1350-9047 Impact factor: 12.067